We have posted frequently about threats to the integrity of the clinical evidence-based, and to the practice of evidence-based medicine. In particular, we have discussed how research may be manipulated in favor of vested interests, or suppressed when the results do not favor such interests.Last week, the British Medical Journal electronically published a set of guidelines for how industry sponsored clinical research ought to be published, sponsored by the International Society for Medical Publication Professionals. The authors came from pharmaceutical companies (Johnson & Johnson, AstraZeneca, Pfizer and Cephalon), medical device companies (LifeScan), and medical publishing and medical education and communication companies (John Wiley...